View in EDS PDF Full Text

Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.

Saved in:
Bibliographic Details
Title: Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
Authors: Frecot DI; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Blaess S; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany., Wagner TR; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kaiser PD; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Traenkle B; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Fandrich M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Jakobi M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Scholz AM; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany., Nueske S; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Gouttefangeas C; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Institute for Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany., Kneilling M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University of Tübingen, Tübingen, Germany., Pichler BJ; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany., Sonanini D; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Medical Oncology and Pneumology, University of Tübingen, Tübingen, Germany., Rothbauer U; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
Source: Frontiers in immunology [Front Immunol] 2024 Oct 15; Vol. 15, pp. 1480091. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39474429
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Frecot+DI%22">Frecot DI</searchLink>; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Blaess+S%22">Blaess S</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wagner+TR%22">Wagner TR</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kaiser+PD%22">Kaiser PD</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Traenkle+B%22">Traenkle B</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Fandrich+M%22">Fandrich M</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Jakobi+M%22">Jakobi M</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scholz+AM%22">Scholz AM</searchLink>; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany.<br /><searchLink fieldCode="AU" term="%22Nueske+S%22">Nueske S</searchLink>; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany.<br /><searchLink fieldCode="AU" term="%22Schneiderhan-Marra+N%22">Schneiderhan-Marra N</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gouttefangeas+C%22">Gouttefangeas C</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Institute for Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kneilling+M%22">Kneilling M</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pichler+BJ%22">Pichler BJ</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Sonanini+D%22">Sonanini D</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Medical Oncology and Pneumology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rothbauer+U%22">Rothbauer U</searchLink>; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Oct 15; Vol. 15, pp. 1480091. <i>Date of Electronic Publication: </i>2024 Oct 15 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39474429
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1480091
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1480091
    Titles:
      – TitleFull: Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Frecot DI
      – PersonEntity:
          Name:
            NameFull: Blaess S
      – PersonEntity:
          Name:
            NameFull: Wagner TR
      – PersonEntity:
          Name:
            NameFull: Kaiser PD
      – PersonEntity:
          Name:
            NameFull: Traenkle B
      – PersonEntity:
          Name:
            NameFull: Fandrich M
      – PersonEntity:
          Name:
            NameFull: Jakobi M
      – PersonEntity:
          Name:
            NameFull: Scholz AM
      – PersonEntity:
          Name:
            NameFull: Nueske S
      – PersonEntity:
          Name:
            NameFull: Schneiderhan-Marra N
      – PersonEntity:
          Name:
            NameFull: Gouttefangeas C
      – PersonEntity:
          Name:
            NameFull: Kneilling M
      – PersonEntity:
          Name:
            NameFull: Pichler BJ
      – PersonEntity:
          Name:
            NameFull: Sonanini D
      – PersonEntity:
          Name:
            NameFull: Rothbauer U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 2024 Oct 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1